Mechanisms of Immunosurveillance for Lung Cancer
The purpose of this research study is to investigate the differences in "natural killer (NK) blood cells, a type of white blood cell that fights infection in the body, among different types of patients that have lung surgery. The four different groups of patients are: * smokers with lung cancer * smokers without lung cancer * non-smokers with lung cancer * non-smokers without lung cancer.
Checked against the public recordLast updated May 7, 2018 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Washington University School of Medicine
- Interventions being studied
- Other: blood draw
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Age equal or greater to 18 years * Ability to read and write in English * Able to participate in the informed consent process Exclusion Criteria: * Known active hepatitis B, hepatitis C, or HIV/AIDs (found in medical record) * Chemotherapy or radiation therapy within 3 months of enrollment * Type 1 Diabetes Mellitus * Rheumatoid arthritis, Lupus, Multiple Sclerosis, or any other autoimmune disease as deemed necessary for exclusion by the Principal Investigator * Previous organ transplant * Blood transfusion within 3 months prior to enrollment * Any previous cancer, excluding a previous lung cancer * Steroid use within 4 weeks of enrollment
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Washington University School of MedicineSt Louis, Missouri
Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 7, 2018. Always confirm current availability with the study team.